Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P23219
UPID:
PGH1_HUMAN
Alternative names:
Cyclooxygenase-1; Prostaglandin H2 synthase 1; Prostaglandin-endoperoxide synthase 1
Alternative UPACC:
P23219; A8K1V7; B4DHQ2; B4E2S5; Q15122; Q3HY28; Q3HY29; Q5T7T6; Q5T7T7; Q5T7T8
Background:
Prostaglandin G/H synthase 1, also known as Cyclooxygenase-1, plays a pivotal role in the biosynthesis of prostanoids, crucial for inflammatory responses and gastric cytoprotection. This enzyme catalyzes the conversion of arachidonic acid to prostaglandin G2 and subsequently to prostaglandin H2, the precursor of 2-series prostaglandins and thromboxanes.
Therapeutic significance:
Understanding the role of Prostaglandin G/H synthase 1 could open doors to potential therapeutic strategies, particularly in managing inflammation and gastric epithelial protection.